ArticleslgStudy

biology

Nadofaragene firadenovec

Nadofaragene firadenovec is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Nadofaragene firadenovec rather than just read about it. In short: Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy.

Key takeaways

  • Nadofaragene firadenovec belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Nadofaragene firadenovec to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Nadofaragene firadenovec from memory before moving on to harder problems.

Reference excerpt

Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy. The most common adverse events including laboratory abnormalities, include increased glucose, instillation site discharge, increased triglycerides, fatigue, bladder spasm, micturition urgency, increased creatinine, hematuria, decreased phosphate, chills, dysuria, and pyrexia. Nadofaragene firadenovec was approved for medical use in the United States in December 2022, and in the European Union in May 2026.

Medical uses Nadofaragene firadenovec is indicated for the treatment of adults with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.

History The safety and effectiveness of nadofaragene firadenovec was evaluated in a multi-center clinical study (Study CS-003 (NCT02773849)) that included 157 participants with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, 98 of whom had BCG-unresponsive carcinoma in situ with or without papillary tumors and could be evaluated for response. Participants received nadofaragene firadenovec once every three months for up to twelve months, or until unacceptable toxicity to therapy or recurrent high-grade non-muscle-invasive bladder cancer. Overall, 51% of enrolled participants using nadofaragene firadenovec therapy achieved a complete response (the disappearance of all signs of cancer as seen on cystoscopy, biopsied tissue, and urine). The median duration of response was 9.7 months. Forty-six percent of responding participants remained in complete response for at least one year. The major efficacy outcome measures were complete response at any time and duration of response. Complete response was defined as negative cystoscopy with applicable transurethral resection of bladder tumor and biopsies and urine cytology. Random bladder biopsies of five sites were conducted in participants remaining in complete response at twelve months. The US Food and Drug Administration (FDA) granted the application for nadofaragene firadenovec priority review, breakthrough therapy, fast track, and orphan drug designations. The FDA granted approval of Adstiladrin to Ferring Pharmaceuticals A/S.

Society and culture

Legal status Nadofaragene firadenovec was approved for medical use in the United States in December 2022, and in the European Union in May 2026.

Names Nadofaragene firadenovec is the international nonproprietary name (INN). Nadofaragene firadenovec is sold under the brand name Adstiladrin.

References

External links Clinical trial number NCT02773849 for "Adstiladrin (Instilidrin) in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Nadofaragene firadenovec

Start with the simplest possible case. Write down what Nadofaragene firadenovec claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Nadofaragene firadenovec before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Nadofaragene firadenovec ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Nadofaragene firadenovec

In research
Nadofaragene firadenovec appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Nadofaragene firadenovec in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Nadofaragene firadenovec is common in secondary-school and first-year university syllabi. It links to neighbouring topics Approved gene therapies, Cancer treatments, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life
Look for Nadofaragene firadenovec outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Nadofaragene firadenovec” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Nadofaragene firadenovec in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Nadofaragene firadenovec means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Nadofaragene firadenovec out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Nadofaragene firadenovec in simple terms?

Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. It is a non-replicating (cannot multiply in human cells) adenoviral vector-based gene therapy.

Why does Nadofaragene firadenovec matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Nadofaragene firadenovec?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Nadofaragene firadenovec.

Tags

  • Approved gene therapies
  • Cancer treatments
  • Orphan drugs

Keep exploring